Last update 21 Nov 2024

Autologous tumour infiltrating lymphocyte therapy( Hebei Senlangbio Biotechnology)

Overview

Basic Info

Drug Type
T-lymphocyte cell therapy
Synonyms
Autologous tumour infiltrating lymphocyte therapy - Hebei Senlang Biotechnology
Target-
Mechanism
Immunologic cytotoxicity, T lymphocyte replacements
Therapeutic Areas
NeoplasmsNervous System DiseasesOther Diseases
Active Indication
Glioblastoma Multiforme
Inactive Indication-
Originator Organization
Hebei Senlangbio Biotechnology Co., Ltd.Hebei Senlangbio Biotechnology Co., Ltd.
Active Organization
Hebei Senlangbio Biotechnology Co., Ltd.Hebei Senlangbio Biotechnology Co., Ltd.
Inactive Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Autologous tumour infiltrating lymphocyte therapy( Hebei Senlangbio Biotechnology)
NCT05333588
/ RecruitingEarly Phase 1
The Safety and Efficacy Study of Autologous Tumor-infiltrating Lymphocyte (TILs) Therapy Combined With Conventional Chemotherapy for Patients With Advanced Stage of Glioblastoma Multiforme.
100 Clinical Results associated with Autologous tumour infiltrating lymphocyte therapy( Hebei Senlangbio Biotechnology)
Login to view more data
100 Translational Medicine associated with Autologous tumour infiltrating lymphocyte therapy( Hebei Senlangbio Biotechnology)
Login to view more data
100 Patents (Medical) associated with Autologous tumour infiltrating lymphocyte therapy( Hebei Senlangbio Biotechnology)
Login to view more data
100 Deals associated with Autologous tumour infiltrating lymphocyte therapy( Hebei Senlangbio Biotechnology)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Glioblastoma MultiformePhase 1
CN
Hebei Senlangbio Biotechnology Co., Ltd.Hebei Senlangbio Biotechnology Co., Ltd.
15 Feb 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free